Vaccine delivery by polymeric vehicles in the mouse reproductive tract induces sustained local and systemic immunity

Molecular Pharmaceutics

Volumn 7, Issue 5, 2010, Pages 1585-1595

  Kuo Haller, Patricia ^a   Cu, Yen ^b   Blum, Jeremy ^b   Appleton, Judith A ^c   Saltzman, W Mark ^b  

^a Cornell University   (United States)

^b Yale University   (United States)

^c Department of Obstetrics Gynecology   (United States)

Author keywords

antibodies; mucosal immunization; OVA; polymer; vaccine delivery

Indexed keywords

DRUG VEHICLE; FREUND ADJUVANT; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; OVALBUMIN; POLYMER;

ANTIBODY TITER; ARTICLE; CONTROLLED DRUG RELEASE; FEMALE GENITAL SYSTEM; FEMALE GENITAL TRACT INFECTION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNIZATION; INFECTION PREVENTION; NONHUMAN; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; WART VIRUS;

ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, ORAL; ANIMALS; ANTIBODY SPECIFICITY; DRUG DELIVERY SYSTEMS; FEMALE; IMMUNITY, MUCOSAL; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LACTIC ACID; MICE; MICE, INBRED BALB C; MICROSPHERES; MODELS, IMMUNOLOGICAL; OVALBUMIN; POLYGLYCOLIC ACID; VACCINES; VAGINA;

EID: 77957738079     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp100009e     Document Type: Article

References (53)

1. Iwasaki, A. Mucosal dendritic cells Annu. Rev. Immunol. 2007, 25, 381-418
2. Walker, R. I. New strategies for using mucosal vaccination to achieve more effective immunization Vaccine 1994, 12 (5) 387-400
3. UNAIDS Global summary of the AIDS epidemic. In AIDS Epidemic Update; World Health Organization: 2007.
4. Looker, K. J.; Garnett, G. P.; Schmid, G. P An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection Bull. World Health Org. 2008, 86 (10) 805-812
5. Harper, D. M. Preliminary HPV vaccine results for women older than 25 years Lancet 2009, 373 (9679) 1921-1922
6. de Sanjose, S.; Diaz, M.; Castellsague, X.; Clifford, G.; Bruni, L.; Munoz, N.; Bosch, F. X. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis Lancet Infect. Dis. 2007, 7 (7) 453-459
7. Bosch, F. X.; de Sanjose, S The epidemiology of human papillomavirus infection and cervical cancer Dis. Markers 2007, 23 (4) 213-227
8. Cone, R. A. Barrier properties of mucus Adv. Drug Delivery Rev. 2009, 61 (2) 75-85
9. Mestecky, J.; Moldoveanu, Z.; Russell, M. W. Immunologic uniqueness of the genital tract: challenge for vaccine development Am. J. Reprod. Immunol. 2005, 53 (5) 208-214
10. Mestecky, J.; Russell, M. W.; Elson, C. O. Perspectives on mucosal vaccines: is mucosal tolerance a barrier? J. Immunol. 2007, 179 (9) 5633-5638
11. Parr, M. B.; Parr, E. L. In Handbook of Mucosal Immunology; Ogra, P. L.; Mestecky, J.; Lamm, M. E.; Strober, W.; McGee, J. R.; Bienenstock, J., Eds.; Academic Press, Inc.: San Diego, 1994; pp 677 - 689.
12. Bhavsar, M. D.; Amiji, M. M. Polymeric nano- and microparticle technologies for oral gene delivery Expert Opin. Drug Delivery 2007, 4 (3) 197-213
13. Mundargi, R. C.; Babu, V. R.; Rangaswamy, V.; Patel, P.; Aminabhavi, T. M. Nano/micro technologies for delivering macromolecular therapeutics using poly(D, L-lactide-co-glycolide) and its derivatives J. Controlled Release 2008, 125 (3) 193-209
14. Shive, M. S.; Anderson, J. M. Biodegradation and biocompatibility of PLA and PLGA microspheres Adv. Drug Delivery Rev. 1997, 28 (1) 5-24
15. Perez, C.; Castellanos, I. J.; Costantino, H. R.; Al-Azzam, W.; Griebenow, K. Recent trends in stabilizing protein structure upon encapsulation and release from bioerodible polymers J. Pharm. Pharmacol. 2002, 54 (3) 301-313
16. Di Colo, G. Controlled drug release from implantable matrices based on hydrophobic polymers Biomaterials 1992, 13 (12) 850-856
17. Kuo, P. Y.; Sherwood, J. K.; Saltzman, W. M. Topical antibody delivery systems produce sustained levels in mucosal tissue and blood Nat. Biotechnol. 1998, 16 (2) 163-167
18. Saltzman, W. M.; Sherwood, J. K.; Adams, D. R.; Castle, P.; Haller, P. Long-term vaginal antibody delivery: delivery systems and biodistribution Biotechnol. Bioeng. 2000, 67 (3) 253-264
19. Shen, H.; Goldberg, E.; Saltzman, W. M. Gene expression and mucosal immune responses after vaginal DNA immunization in mice using a controlled delivery matrix J. Controlled Release 2003, 86 (2-3) 339-348
20. Dumais, N.; Patrick, A.; Moss, R. B.; Davis, H. L.; Rosenthal, K. L. Mucosal immunization with inactivated human immunodeficiency virus plus CpG oligodeoxynucleotides induces genital immune responses and protection against intravaginal challenge J. Infect. Dis. 2002, 186 (8) 1098-1105
21. Gallichan, W. S.; Rosenthal, K. L. Long-term immunity and protection against herpes simplex virus type 2 in the murine female genital tract after mucosal but not systemic immunization J. Infect. Dis. 1998, 177 (5) 1155-1161
22. Gallichan, W. S.; Woolstencroft, R. N.; Guarasci, T.; McCluskie, M. J.; Davis, H. L.; Rosenthal, K. L. Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract J. Immunol. 2001, 166 (5) 3451-3457
23. Allaoui-Attarki, K.; Fattal, E.; Pecquet, S.; Trolle, S.; Chachaty, E.; Couvreur, P.; Andremont, A. Mucosal immunogenicity elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly (D, L-lactide-co- glycolide) microspheres Vaccine 1998, 16 (7) 685-691
24. Challacombe, S. J.; Rahman, D.; O'Hagan, D. T. Salivary, gut, vaginal and nasal antibody responses after oral immunization with biodegradable microparticles Vaccine 1997, 15 (2) 169-175
25. Chattaraj, S. C.; Rathinavelu, A.; Das, S. K. Biodegradable microparticles of influenza viral vaccine: comparison of the effects of routes of administration on the in vivo immune response in mice J. Controlled Release 1999, 58 (2) 223-232
26. He, X. W.; Wang, F.; Jiang, L.; Li, J.; Liu, S. K.; Xiao, Z. Y.; Jin, X. Q.; Zhang, Y. N.; He, Y.; Li, K.; Guo, Y. J.; Sun, S. H. Induction of mucosal and systemic immune response by single-dose oral immunization with biodegradable microparticles containing DNA encoding HBsAg J. Gen. Virol. 2005, 86 (Part 3) 601-610
27. Livingston, J. B.; Lu, S.; Robinson, H.; Anderson, D. J. Immunization of the female genital tract with a DNA-based vaccine Infect. Immun. 1998, 66 (1) 322-329
28. Luci, C.; Hervouet, C.; Rousseau, D.; Holmgren, J.; Czerkinsky, C.; Anjuere, F. Dendritic cell-mediated induction of mucosal cytotoxic responses following intravaginal immunization with the nontoxic B subunit of cholera toxin J. Immunol. 2006, 176 (5) 2749-2757
29. Kwant, A.; Rosenthal, K. L. Intravaginal immunization with viral subunit protein plus CpG oligodeoxynucleotides induces protective immunity against HSV-2 Vaccine 2004, 22 (23-24) 3098-3104
30. Kato, H.; Bukawa, H.; Hagiwara, E.; Xin, K. Q.; Hamajima, K.; Kawamoto, S.; Sugiyama, M.; Sugiyama, M.; Noda, E.; Nishizaki, M.; Okuda, K. Rectal and vaginal immunization with a macromolecular multicomponent peptide vaccine candidate for HIV-1 infection induces HIV-specific protective immune responses Vaccine 2000, 18 (13) 1151-1160
31. Wyatt, T. L.; Whaley, K. J.; Cone, R. A.; Saltzman, W. M. Antigen-releasing polymer rings and microspheres stimulate mucosal immunity in the vagina J. Controlled Release 1998, 50 (1-3) 93-102
32. Tengvall, S.; O'Hagan, D.; Harandi, A. M. Rectal immunization generates protective immunity in the female genital tract against herpes simplex virus type 2 infection: relative importance of myeloid differentiation factor 88 Antiviral Res. 2008, 78 (3) 202-214
33. Park, J. S.; Oh, Y. K.; Kang, M. J.; Kim, C. K. Enhanced mucosal and systemic immune responses following intravaginal immunization with human papillomavirus 16 L1 virus-like particle vaccine in thermosensitive mucoadhesive delivery systems J. Med. Virol. 2003, 70 (4) 633-641
34. Mestecky, J.; Abraham, R.; Ogra, P. L. Handbook of Mucosal Immunology; Ogra, P. L.; Mestecky, J.; Lamm, M. E.; Strober, W.; McGee, J. R., Eds.; Academic Press, Inc.: New York, 1994; pp 357 - 372.
35. Scicchitano, R. A.; Stanisz, P.; Ernst, P.; Bienenstock, J. In Migration and Homing of Lymphoid Cells, Vol. II; Husband, A., Ed.; CRC Press: Boca Raton, 1988; pp 1 - 34.
36. Phillips-Quagliata, J. M.; Lamm, M. E. In Migration and Homing of Lymphoid Cells, Vol. II; CRC Press: Husband, A., Ed.; Boca Raton, 1988; pp 53 - 75.
37. Akagi, T.; Kawamura, M.; Ueno, M.; Hiraishi, K.; Adachi, M.; Serizawa, T.; Akashi, M.; Baba, M. Mucosal immunization with inactivated HIV-1-capturing nanospheres induces a significant HIV-1-specific vaginal antibody response in mice J. Med. Virol. 2003, 69 (2) 163-172
38. Akagi, T.; Ueno, M.; Hiraishi, K.; Baba, M.; Akashi, M. AIDS vaccine: Intranasal immunization using inactivated HIV-1-capturing core-corona type polymeric nanospheres J. Controlled Release 2005, 109 (1-3) 49-61
39. Barnett, S. W.; Srivastava, I. K.; Kan, E.; Zhou, F.; Goodsell, A.; Cristillo, A. D.; Ferrai, M. G.; Weiss, D. E.; Letvin, N. L.; Montefiori, D.; Pal, R.; Vajdy, M. Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope Aids 2008, 22 (3) 339-348
40. Kozlowski, P. A.; Cu-Uvin, S.; Neutra, M. R.; Flanigan, T. P. Mucosal vaccination strategies for women J. Infect. Dis. 1999, 179 Suppl. 3, S493-498
41. Parr, E. L.; Parr, M. B. Immune responses and protection against vaginal infection after nasal or vaginal immunization with attenuated herpes simplex virus type-2 Immunology 1999, 98 (4) 639-645
42. O'Hagan, D. T.; Rahman, D.; McGee, J. P.; Jeffery, H.; Davies, M. C.; Williams, P.; Davis, S. S.; Challacombe, S. J. Biodegradable microparticles as controlled release antigen delivery systems Immunology 1991, 73 (2) 239-242
43. Elson, C. O.; Ealding, W.; Lefkowitz, J. A lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretions J. Immunol. Methods 1984, 67, 101-108
44. Challacombe, S. J.; Rahman, D.; Jeffery, H.; Davis, S. S.; O'Hagan, D. T. Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen Immunology 1992, 76 (1) 164-168
45. Ott, R. L. An Introduction to Statistical Methods and Data Analysis; Wadsworth Publishing Company: Belmont, 1993.
46. Tabata, Y.; Inoue, Y.; Ikada, Y. Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable microspheres Vaccine 1996, 14 (17-18) 1677-1685
47. Saltzman, W. M.; Langer, R. Transport rates of proteins in porous materials with known microgeometry Biophys. J. 1989, 55 (1) 163-171
48. Kutteh, W. H. In Mucosal Immunology; Ogra, P. L.; Mestecky, J.; Lamm, M. E.; Strober, W.; Bienenstock, J.; McGee, J. R., Eds.; Academic Press: New York, 1999; pp 1423 - 1434.
49. Kanazawa, T.; Takashima, Y.; Hirayama, S.; Okada, H. Effects of menstrual cycle on gene transfection through mouse vagina for DNA vaccine Int. J. Pharm. 2008, 360 (1-2) 164-170
50. Aicher, W. K.; Fujihashi, K.; Yamamoto, M.; Kiyono, H.; Pitts, A. M.; McGhee, J. R. Effects of the lpr/lpr mutation on T and B cell populations in the lamina propria of the small intestine, a mucosal effector site Int. Immunol. 1992, 4 (9) 959-968
51. Brandtzaeg, P.; Farstad, I. N.; Johansen, F. E.; Morton, H. C.; Norderhaug, I. N.; Yamanaka, T. The B-cell system of human mucosae and exocrine glands Immunol. Rev. 1999, 171, 45-87
52. De, F.; Bernardis, M.; Boccanera, D; Adriani, A.; Girolamo, A. Cassone, Intravaginal and intranasal immunizations are equally effective in inducing vaginal antibodies and conferring protection against vaginal candidiasis Infect. Immun. 2002, 70 (5) 2725-2729
53. Russell, M. W.; Mestecky, J. Humoral immune responses to microbial infections in the genital tract Microbes Infect. 2002, 4 (6) 667-677